These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 24928107)

  • 21. [Epidemiological and clinical features of occult hepatitis B in HIV infection without antiretroviral treatment].
    Zhang RF; Liu L; Zheng YF; Shen YZ; Chen J; Gu SM; Wang JR; Lu HZ
    Zhonghua Gan Zang Bing Za Zhi; 2013 Mar; 21(3):189-91. PubMed ID: 23967739
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Red cell alloimmunization and infectious marker status (human immunodeficiency virus, hepatitis B virus and hepatitis C virus) in multiply transfused thalassemia patients of North India.
    Makroo RN; Arora JS; Chowdhry M; Bhatia A; Thakur UK; Minimol A
    Indian J Pathol Microbiol; 2013; 56(4):378-83. PubMed ID: 24441225
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Occult Hepatitis B Virus Infection among β-Thalassemia Major Patients in Ahvaz City, Iran.
    Amirhashchi F; Azaran A; Seyedian SS; Jalilian S; Keikhaei B
    Am J Trop Med Hyg; 2021 Oct; 106(1):174-181. PubMed ID: 34607305
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatitis B virus infection among first-time blood donors in Italy: prevalence and correlates between serological patterns and occult infection.
    Romanò L; Velati C; Cambiè G; Fomiatti L; Galli C; Zanetti AR;
    Blood Transfus; 2013 Apr; 11(2):281-8. PubMed ID: 23399361
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transmission of occult hepatitis B virus by transfusion to adult and pediatric recipients in Taiwan.
    Liu CJ; Lo SC; Kao JH; Tseng PT; Lai MY; Ni YH; Yeh SH; Chen PJ; Chen DS
    J Hepatol; 2006 Jan; 44(1):39-46. PubMed ID: 16168517
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibody to hepatitis B core antigen as a screening test for occult hepatitis B virus infection in Egyptian chronic hepatitis C patients.
    El-Sherif A; Abou-Shady M; Abou-Zeid H; Elwassief A; Elbahrawy A; Ueda Y; Chiba T; Hosney AM
    J Gastroenterol; 2009; 44(4):359-64. PubMed ID: 19271112
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Occult hepatitis B virus infection among blood donors from the Brazilian Amazon: implications for transfusion policy.
    Moresco MN; Virgolino Hde A; de Morais MP; da Motta-Passos I; Gomes-Gouvêa MS; de Assis LM; Aguiar KR; Lombardi SC; Malheiro A; Cavalheiro Nde P; Levi JE; Torres KL
    Vox Sang; 2014 Jul; 107(1):19-25. PubMed ID: 24697276
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nationwide nucleic acid amplification testing of hepatitis B virus, hepatitis C virus and human immunodeficiency virus type 1 for blood transfusion and follow-up study of nucleic acid amplification positive donors.
    Japanese Red Cross NAT Screening Research Group
    Jpn J Infect Dis; 2000 Jun; 53(3):116-23. PubMed ID: 10957709
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Occult hepatitis B virus infection as a cause of posttransfusion hepatitis in patients with cancers.
    Sodhi JS; Wani N; Jeelani S; Geelani S; Akhtar F; Javid G; Yattoo GN; Shah A; Gulzar GM; Khan MA; Parveen S; Saif RU; Showkat A
    Indian J Gastroenterol; 2013 Sep; 32(5):291-6. PubMed ID: 23512211
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NAT for HBV and anti-HBc testing increase blood safety.
    Roth WK; Weber M; Petersen D; Drosten C; Buhr S; Sireis W; Weichert W; Hedges D; Seifried E
    Transfusion; 2002 Jul; 42(7):869-75. PubMed ID: 12375659
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lack of occult hepatitis B virus infection among blood donors with isolated hepatitis B core antibody living in an HBV low prevalence region of Iran.
    Sofian M; Aghakhani A; Izadi N; Banifazl M; Kalantar E; Eslamifar A; Ramezani A
    Int J Infect Dis; 2010 Apr; 14(4):e308-10. PubMed ID: 19656713
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of HBV and HCV infection among multi-transfused Egyptian thalassemic patients.
    Mansour AK; Aly RM; Abdelrazek SY; Elghannam DM; Abdelaziz SM; Shahine DA; Elmenshawy NM; Darwish AM
    Hematol Oncol Stem Cell Ther; 2012; 5(1):54-9. PubMed ID: 22446611
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Can the serological status of anti-HBc alone be considered a sentinel marker for detection of occult HBV infection?
    Vitale F; Tramuto F; Orlando A; Vizzini G; Meli V; Cerame G; Mazzucco W; Virdone R; Palazzo U; Villafrate MR; Tagger A; Romano N
    J Med Virol; 2008 Apr; 80(4):577-82. PubMed ID: 18297707
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HBsAg seropositivity among multi-transfused thalassemic children.
    Khakhkhar V; Joshi PJ
    Indian J Pathol Microbiol; 2006 Oct; 49(4):516-8. PubMed ID: 17183840
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Occult hepatitis B virus infection in hemodialysis patients with isolated hepatitis B core antibody: a multicenter study.
    Aghakhani A; Banifazl M; Kalantar E; Eslamifar A; Ahmadi F; Razeghi E; Atabak S; Amini M; Khadem-Sadegh A; Ramezani A
    Ther Apher Dial; 2010 Jun; 14(3):349-53. PubMed ID: 20609190
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical significance of occult hepatitis B virus infection in chronic hepatitis C patients.
    Jang JY; Jeong SW; Cheon SR; Lee SH; Kim SG; Cheon YK; Kim YS; Cho YD; Kim HS; Jin SY; Kim YS; Kim BS
    Korean J Hepatol; 2011 Sep; 17(3):206-12. PubMed ID: 22102387
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PREVALENCE OF OCCULT HEPATITIS B INFECTION IN IRANIAN CANCER PATIENTS BEFORE CHEMOTHERAPY TREATMENT.
    Baghbanian M; Halvani M; Roghani HS; Lotfi MH; Yazdi MF; Vahedian-Ardakani HA
    Arq Gastroenterol; 2016; 53(3):175-9. PubMed ID: 27438423
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Occult hepatitis B virus infection in the setting of hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection: clinically relevant or a diagnostic problem?
    Rodríguez-Torres M; Gonzalez-Garcia J; Bräu N; Solá R; Moreno S; Rockstroh J; Smaill F; Mendes-Correa MC; DePamphilis J; Torriani FJ;
    J Med Virol; 2007 Jun; 79(6):694-700. PubMed ID: 17457912
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low levels of awareness, vaccine coverage, and the need for boosters among health care workers in tertiary care hospitals in India.
    Sukriti ; Pati NT; Sethi A; Agrawal K; Agrawal K; Kumar GT; Kumar M; Kaanan AT; Sarin SK
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1710-5. PubMed ID: 18761556
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The detection of occult HBV infection in patients with HBsAg negative pattern by real-time PCR method.
    Izmirli S; Celik DG; Yuksel P; Saribas S; Aslan M; Ergin S; Bahar H; Sen S; Cakal B; Oner A; Kocazeybek B
    Transfus Apher Sci; 2012 Dec; 47(3):283-7. PubMed ID: 23021041
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.